Our team is here to help you with all your dental and medical needs.
For general information only — not a substitute for professional advice. In an emergency call 999, visit A&E, or call NHS 111.
As awareness of sexual health continues to grow, more people are encountering terms like mycoplasma and ureaplasma — and asking an important question: are these infections considered sexually transmitted, or are they naturally occurring bacteria? The answer is not always straightforward, and the distinction matters when it comes to understanding transmission, symptoms, and the role of testing.
Unlike more widely recognised STIs such as chlamydia or gonorrhoea, mycoplasma and ureaplasma occupy a more nuanced space in sexual health. Some species are commonly associated with sexual contact, while others may be present in the genital tract without causing any issues at all.
This guide explores what mycoplasma and ureaplasma are, how they are transmitted, what symptoms they may cause, and when private STI screening may be appropriate for clarity.
Mycoplasma and ureaplasma are types of bacteria that can be present in the genital tract. Some species, such as Mycoplasma genitalium, are commonly associated with sexual transmission, while others may exist without causing symptoms. Because their role can vary, testing is often required to determine their presence and relevance in a clinical context.
Mycoplasma and ureaplasma are genera of very small bacteria that can be found in the urogenital tract. They belong to a broader class of organisms known as mollicutes, which are distinguished by their lack of a cell wall — making them biologically distinct from many other types of bacteria.
Several species exist within each genus. Among the most commonly discussed are Mycoplasma genitalium, which is frequently studied in the context of sexual health, and Ureaplasma urealyticum, which is often identified during urogenital investigations. Mycoplasma hominis is another species that may be detected in the genital tract.
It is important to understand that the presence of these bacteria does not always indicate disease. In some individuals, they may exist as part of the normal microbiota without causing symptoms or requiring intervention. In other cases, they may be associated with urogenital symptoms that warrant further investigation through testing.
One of the most common questions people ask is whether mycoplasma is an STI. The answer depends partly on the species involved and partly on the clinical context. Mycoplasma genitalium, for example, is widely recognised as being sexually transmitted and is increasingly included in STI screening panels. Its association with sexual contact is well-documented, and it is often discussed alongside other common sexually transmitted infections.
The question of whether ureaplasma is an STI is similarly nuanced. Ureaplasma species can be transmitted through sexual contact, but they are also found in the genital tract of individuals who are asymptomatic, and their clinical significance is not always clear-cut. As a result, ureaplasma is not always classified or discussed in the same way as traditional STIs such as chlamydia or gonorrhoea.
This variability in classification can be confusing, but the key takeaway is that some species — particularly Mycoplasma genitalium — are commonly associated with sexual transmission, while the significance of others may depend on individual circumstances. Testing helps to clarify whether these organisms are present and whether further guidance may be appropriate.
The primary route of Mycoplasma genitalium transmission is through sexual contact, including vaginal, anal, and potentially oral sexual activity. This places it firmly within the category of infections that are commonly discussed in sexual health contexts.
Ureaplasma transmission can also occur through sexual contact, though the picture is more complex. Ureaplasma species may be present in the genital tract of some individuals as part of their natural microbiota, meaning that detection does not always indicate recent sexual transmission. However, sexual contact remains a recognised route through which these organisms can be passed between partners.
In both cases, transmission may occur without either partner experiencing symptoms at the time. This silent transfer is one of the reasons why testing plays such an important role — particularly after new or unprotected sexual contact.
No — and this is one of the most important aspects to understand about mycoplasma and ureaplasma. Many individuals who carry these bacteria experience no symptoms whatsoever. The infection, or colonisation, may go entirely unnoticed without laboratory testing.
When symptoms do occur, they are often mild and can easily be mistaken for other conditions. Urinary discomfort, for example, may be attributed to a urinary tract infection rather than a mycoplasma or ureaplasma-related issue. This overlap with other conditions makes clinical assessment based on symptoms alone unreliable.
Because of this variability, testing is required to confirm whether these organisms are present. Symptom-based assessment is insufficient for identifying infections that may produce no signs, or signs that closely resemble unrelated conditions.
While many cases remain asymptomatic, some individuals may experience symptoms that could potentially be associated with mycoplasma or ureaplasma. Common mycoplasma symptoms and ureaplasma symptoms may include:
It is worth emphasising that these symptoms are not unique to mycoplasma or ureaplasma and may be caused by other conditions entirely. They should not be used as a basis for self-assessment. If any of these symptoms are experienced, testing can help determine whether these organisms are involved.
There are several situations in which testing for mycoplasma and ureaplasma may be worth considering:
Testing for these organisms is becoming more accessible and is increasingly included in comprehensive screening panels. Rather than waiting for symptoms to develop — or hoping they resolve on their own — screening provides a reliable way to understand your status.
The fundamental challenge with mycoplasma and ureaplasma is that symptoms are often unreliable indicators. An individual may carry one or both organisms without any physical signs, or may experience symptoms that could equally be attributed to another condition.
Laboratory testing resolves this uncertainty. Modern PCR-based testing is highly sensitive and can detect the presence of specific organisms with a high degree of accuracy, even when no symptoms are present. This makes testing the only reliable way to confirm whether mycoplasma or ureaplasma is present.
Testing is required to confirm the presence of these organisms. Symptoms alone cannot reliably determine whether mycoplasma or ureaplasma is involved.
Private STI testing for mycoplasma and ureaplasma is designed to be a straightforward, discreet, and confidential process. At a Private Sexual Health Clinic, testing is conducted in a professional clinical environment with strict confidentiality maintained throughout.
The type of sample required depends on the specific test. A Mycoplasma genitalium PCR test typically uses a urine sample or swab to detect the presence of the organism with high sensitivity. Similarly, a Ureaplasma PCR test follows the same approach, using molecular analysis to identify the bacteria accurately.
For individuals who wish to screen for a broader range of infections in a single appointment, a Comprehensive STI testing panel may be appropriate. Samples are processed by accredited laboratories, and results are communicated through a secure, confidential process.
MD.co.uk provides private STI testing, blood tests, and health screening only. No GP consultations or treatment services are offered. If test results indicate the presence of an infection, appropriate next steps can be discussed, which may include referral to a treatment provider.
As with other sexually transmitted organisms, the risk of acquiring mycoplasma or ureaplasma can be reduced through certain measures, although no method provides complete protection. Barrier protection such as condoms may help reduce the likelihood of transmission during sexual contact, though their effectiveness may vary depending on the nature of the contact.
Regular testing supports early detection, which is particularly important given that many cases are asymptomatic. Being aware of your own status — and communicating with partners about sexual health — are practical steps that contribute to a more informed approach to prevention.
Ultimately, prevention is best understood as a combination of barrier use, awareness, communication, and routine screening rather than any single measure in isolation.
Mycoplasma and ureaplasma are organisms that exist in a space between clearly classified STIs and naturally occurring bacteria. Understanding this distinction is important for making informed decisions about sexual health and testing.
Mycoplasma genitalium is commonly associated with sexual transmission, although classification may vary depending on clinical context.
Ureaplasma can be transmitted through sexual contact, but it may also exist without causing symptoms in some individuals.
No, many individuals may carry these bacteria without noticeable symptoms.
They are typically identified through laboratory testing using urine samples or swabs.
Testing may be considered if symptoms are present or as part of broader STI screening.
This article is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Sexual health concerns should be assessed based on individual circumstances. If you are experiencing persistent, severe, or worsening symptoms, consultation with an appropriate healthcare service is advised. Our clinic provides private STI testing services only.
Next Review Due: 26 March 2027